Impaired oxytocin signalling in the central amygdala in rats with chronic heart failure
The Journal of Physiology · 2024
DOI: 10.1113/jp286297 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiology, 2024. Verfasst von Ferdinand Althammer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Oxytocin, Heart Failure, Central Amygdaloid Nucleus, Receptors, Oxytocin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHLBI NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) patients suffer from cognitive decline and mood impairments, but the molecular signals and brain circuits underlying these effects remain elusive. The hypothalamic neuropeptide oxytocin (OT) is critically involved in regulating mood, and OTergic signalling in the central amygdala (CeA) is a key mechanism that controls emotional responses including anxiety‐like behaviours. Still, whether an altered OTergic signalling contributes to mood disorders in HF remains unknown. To address this, we used an ischaemic rat HF model, along with a highly multidisciplinary approach, to mechanistically study multiple levels of the hypothalamus‐to‐CeA OTergic circuit in male rats with HF. We aimed to test the hypothesis that sustained activation of the OT system following an infarct leads to depletion of OT content in this pathway, with subsequent changes in OT receptor expression and blunted modulation of local GABAergic circuits. We found that most of OTergic innervation of the CeA originated from the supraoptic nucleus (SON). While no differences in the numbers of SON→CeA OTergic neurons was observed between sham and HF rats, we observed a blunted content and release of OT from axonal terminals within the CeA. Moreover, we report downregulation of neuronal and astrocytic OT receptors, and impaired OTR‐driven GABAergic synaptic activity within the CeA microcircuit of HF rats. We provide the first evidence that male HF rats display perturbations in the hypothalamus‐to‐amygdala OTergic circuit, laying the foundation for future translational studies targeting either the OT system or GABAergic amygdalar microcircuit to ameliorate mood impairments in rats or patients with chronic HF. image Key points Heart failure patients suffer from cognitive decline, depression and mood impairments, but the underlying mechanisms remain elusive. Acting within the central amygdala, the neuropeptide oxytocin regulates emotional responses, including anxiety‐like behaviours. However, whether changes in oxytocin signalling occurs during heart failure is unknown. In this study, we used an ischaemic rat heart failure model to mechanistically study multiple levels of the hypothalamus‐to‐amygdala oxytocinergic circuit in this disease. We report an overall blunted oxytocinergic signalling pathway in rats with heart failure, including blunted content and release of oxytocin from axonal terminals, downregulation of neuronal and astrocytic oxytocin receptors, and impaired oxytocin‐driven GABAergic synaptic activity within the central amygdala microcircuit of HF rats. These studies shed light on mechanisms that contribute to mood disorders in cardiovascular disease states and help to identify potential molecular targets for their improved treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, GA, USA.
- Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
- Neuroscience Institute, Georgia State University, Atlanta, GA, USA.
- Department of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.
- Centre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, Strasbourg, France.
ORCID-Profile: Ranjan K Roy, Matthew K Kirchner, Elba Campos Lira, Stephanie Schimmer, Alexandre Charlet, Javier E Stern
Förderung
- NINDS NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Althammer, F., Roy, R. K., Kirchner, M. K., Lira, E. C., Schimmer, S., Charlet, A., Grinevich, V., & Stern, J. E. (2024). Impaired oxytocin signalling in the central amygdala in rats with chronic heart failure. The Journal of Physiology. https://doi.org/10.1113/jp286297
Vancouver
Althammer F, Roy RK, Kirchner MK, Lira EC, Schimmer S, Charlet A, et al. Impaired oxytocin signalling in the central amygdala in rats with chronic heart failure. The Journal of Physiology. 2024. doi:10.1113/jp286297
BibTeX
@article{Althammer2024,
author = {Althammer, Ferdinand and Roy, Ranjan K and Kirchner, Matthew K and Lira, Elba Campos and Schimmer, Stephanie and Charlet, Alexandre and Grinevich, Valery and Stern, Javier E},
title = {Impaired oxytocin signalling in the central amygdala in rats with chronic heart failure},
journal = {The Journal of Physiology},
year = {2024},
doi = {10.1113/jp286297}
}
EUVIMED